MoneyWorks4Me

Vivimed Labs informs about disclosure of related party transactions

18 Jun 2022 Evaluate

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 (Listing Regulations), Vivimed Labs has informed that it enclosed Related Party Transactions on a consolidated basis for the half year ended 31.03.2022. The financial results have been approved by the Board of Directors on 03.06.2022.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..